399441 生物医药
已收盘 02-26 15:00:00
资讯
新帖
简况
四川双马：持续推进生物医药板块的深度布局与高质量发展
证券之星 · 16:33
四川双马：持续推进生物医药板块的深度布局与高质量发展
天辰生物医药再度递表港交所
智通财经 · 06:31
天辰生物医药再度递表港交所
生物医药企业Polaryx直接上市：市值1.24亿美元 9个月净亏749万美元
雷递 · 02-23 22:16
生物医药企业Polaryx直接上市：市值1.24亿美元 9个月净亏749万美元
生物医药企业Polaryx直接上市：市值1.26亿美元 9个月亏749万美元
雷递网 · 02-20
生物医药企业Polaryx直接上市：市值1.26亿美元 9个月亏749万美元
大兴机场临空区，国际生物医药园（二期）冲出正负零
新京报 · 02-14
大兴机场临空区，国际生物医药园（二期）冲出正负零
派格生物医药-B股价下跌5.54%，受板块走弱及利好兑现影响
经济观察网 · 02-14
派格生物医药-B股价下跌5.54%，受板块走弱及利好兑现影响
派格生物医药-B获纳入恒生综合指数 有望成为港股通标的
智通财经 · 02-14
派格生物医药-B获纳入恒生综合指数 有望成为港股通标的
成大生物（688739）披露拟参与设立5.02亿元生物医药产业投资基金，2月5日股价上涨0.39%
证券之星 · 02-05
成大生物（688739）披露拟参与设立5.02亿元生物医药产业投资基金，2月5日股价上涨0.39%
港股生物医药板块走高，诺诚健华、再鼎医药涨超4%，药明康德、药明生物等个股跟涨
老虎资讯综合 · 02-05
港股生物医药板块走高，诺诚健华、再鼎医药涨超4%，药明康德、药明生物等个股跟涨
2月2日长春高新跌6.14%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 02-02
2月2日长春高新跌6.14%，招商国证生物医药指数(LOF)C基金重仓该股
天溯计量：此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践
证券之星 · 01-29
天溯计量：此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践
四川双马：专注于生物医药领域创新药孵化
证券之星 · 01-27
四川双马：专注于生物医药领域创新药孵化
成大生物最新公告：拟与控股股东等共同设立生物医药产业投资基金
证券之星 · 01-26
成大生物最新公告：拟与控股股东等共同设立生物医药产业投资基金
1月26日智飞生物涨14.87%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 01-26
1月26日智飞生物涨14.87%，招商国证生物医药指数(LOF)C基金重仓该股
港股生物医药股普涨！康方生物涨超5%，荣昌生物涨超3%
老虎资讯综合 · 01-23
港股生物医药股普涨！康方生物涨超5%，荣昌生物涨超3%
近五成生物医药公司业绩预喜 多家CXO企业表现亮眼
南方财经网 · 01-23
近五成生物医药公司业绩预喜 多家CXO企业表现亮眼
港股异动 | 维亚生物(01873)盘中涨近7% 维亚生物创新研讨会呈现生物医药研发新路径
智通财经 · 01-22
港股异动 | 维亚生物(01873)盘中涨近7% 维亚生物创新研讨会呈现生物医药研发新路径
招商基金侯昊旗下招商国证生物医药年报最新持仓，重仓药明康德
证券之星 · 01-21
招商基金侯昊旗下招商国证生物医药年报最新持仓，重仓药明康德
1月19日智飞生物跌7.19%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 01-19
1月19日智飞生物跌7.19%，招商国证生物医药指数(LOF)C基金重仓该股
【新股IPO】成都赜灵生物医药科技股份有限公司向港交所主板提交上市申请
金吾财讯 · 01-13
【新股IPO】成都赜灵生物医药科技股份有限公司向港交所主板提交上市申请
暂无数据
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2179.85,"timestamp":1772089380000,"preClose":2199.37,"halted":0,"volume":326555793,"delay":0,"changeRate":-0.0089,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-19.52,"latestTime":"02-26 15:00:00","open":2202.06,"high":2204.6,"low":2177.33,"amount":12988999999.999998,"amplitude":0.0124,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772155800000},"marketStatusCode":5,"adr":0,"adjPreClose":2199.37,"symbolType":"index","openAndCloseTimeList":[[1772069400000,1772076600000],[1772082000000,1772089200000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441/tweets","defaultTab":"tweets","newsList":[{"id":"2614501352","title":"四川双马：持续推进生物医药板块的深度布局与高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614501352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614501352?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:33","pubTimestamp":1772094795,"startTime":"0","endTime":"0","summary":"四川双马回复：您好，近年来，公司业务已基本成型，形成了以投资带产业的发展模式，基金投资布局科创领域、战略新兴产业等，并通过直投和投资孵化器平台的方式布局了生物医药等科创领域，进一步优化业务布局，拓宽发展空间，整体经营活力与发展潜力持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600024275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0021","161726","BK0235","399441","000935","BK0004"],"gpt_icon":0},{"id":"2614805743","title":"天辰生物医药再度递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614805743?lang=zh_cn&edition=full","pubTime":"2026-02-26 06:31","pubTimestamp":1772058660,"startTime":"0","endTime":"0","summary":"据港交所2月25日披露，天辰生物医药(苏州)股份有限公司(简称：天辰生物医药)向港交所主板递交上市申请，国金证券(香港)为独家保荐人。该公司曾于2025年8月21日递表港交所。招股书显示，天辰 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260226/c674918194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["399441","161726"],"gpt_icon":0},{"id":"2613762557","title":"生物医药企业Polaryx直接上市：市值1.24亿美元 9个月净亏749万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613762557","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613762557?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:16","pubTimestamp":1771856160,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 2月23日生物医药企业Polaryx Therapeutics日前在美国纳斯达克直接上市，截至目前，公司市值为1.24亿美元。Polaryx主要产品候选PLX-200针对多种LSDs，正在进入临床试验阶段。Polaryx的药物开发战略致力于提供安全、有效和患者友好的治疗方案，以满足这些疾病的重大未满足需求。Polaryx准备在2026年上半年启动SOTERIA试验。Polaryx在2023年、2024年净亏损分别为378万美元、3036万美元；2025年前9个月净亏损为749万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661666034&idx=5&sn=e58d294c1a50415d06f935294752ef10&chksm=bdc741008ab0c81652a121815cd0950ba41e70114cb208f0968d211a054f17b83e28e236e856#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["161726","399441"],"gpt_icon":0},{"id":"2612266839","title":"生物医药企业Polaryx直接上市：市值1.26亿美元 9个月亏749万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266839","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612266839?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:42","pubTimestamp":1771584176,"startTime":"0","endTime":"0","summary":"生物医药企业Polaryx Therapeutics（股票代码：“PLYX”）日前在美国纳斯达克直接上市，截至目前，公司市值为1.26亿美元。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32697/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["161726","LABU","BK4585","BK4588","399441"],"gpt_icon":0},{"id":"2611118298","title":"大兴机场临空区，国际生物医药园（二期）冲出正负零","url":"https://stock-news.laohu8.com/highlight/detail?id=2611118298","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611118298?lang=zh_cn&edition=full","pubTime":"2026-02-14 12:39","pubTimestamp":1771043940,"startTime":"0","endTime":"0","summary":"新京报讯 据“这里是大兴”微信公众号消息，大兴机场综保区内，随着最后一方混凝土浇筑完成，国际生物医药园 项目顺利冲出正负零建设节点，迈入主体结构施工新阶段。作为临空区投运的首个生物医药标厂项目，综保区国际生物医药园（一期）自2023年投入运营以来，凭借综保区特有的保税研发、保税生产等政策优势，已初步形成产业集聚。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1771041749129846.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1771041749129846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["399441","161726","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2611811855","title":"派格生物医药-B股价下跌5.54%，受板块走弱及利好兑现影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2611811855","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611811855?lang=zh_cn&edition=full","pubTime":"2026-02-14 12:07","pubTimestamp":1771042020,"startTime":"0","endTime":"0","summary":"经济观察网 派格生物医药-B（02565.HK）股价于2月13日下跌5.54%，收报63.05港元。此次下跌主要受市场整体走弱、纳入指数利好兑现、技术面承压、资金面分歧及高估值压力等多重因素影响。股票 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260214/c674819133.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260214/c674819133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2611191505","title":"派格生物医药-B获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2611191505","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611191505?lang=zh_cn&edition=full","pubTime":"2026-02-14 08:01","pubTimestamp":1771027260,"startTime":"0","endTime":"0","summary":"2月13日，恒生指数公司宣布截至2025年12月31日之恒生指数系列季度检讨结果，其中派格生物医药-B(02565)获纳入恒生综合指数。变动将于2026年3月6日(星期五)收市后实施并于2026年3月9日(星期 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260214/c674813797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2609309248","title":"成大生物（688739）披露拟参与设立5.02亿元生物医药产业投资基金，2月5日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309248","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309248?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:26","pubTimestamp":1770301580,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，成大生物报收于25.89元，较前一交易日上涨0.39%，最新总市值为107.82亿元。该股当日开盘25.8元，最高26.07元，最低25.71元，成交额达5943.37万元，换手率为0.55%。近日，辽宁成大生物股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示，公司拟与控股股东辽宁成大及其全资子公司共同发起设立成大生物医药产业投资基金，基金设立规模为50,200万元，公司作为有限合伙人认缴出资4亿元。本次事项构成关联交易，需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","688739","BK0239","399441"],"gpt_icon":0},{"id":"1197197181","title":"港股生物医药板块走高，诺诚健华、再鼎医药涨超4%，药明康德、药明生物等个股跟涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1197197181","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197197181?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:24","pubTimestamp":1770276262,"startTime":"0","endTime":"0","summary":"2月5日，港股$生物(000504)$医药板块走高，$诺诚健华(09969)$、$再鼎医药(09688)$涨超4%，$药明康德(02359)$、$药明$生物(000504)$(02269)$等个股跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4d7f9f320a213719065b5b2c9bc96e8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","09688","LU0348735423.USD","LU0708995583.HKD","LU0417516738.SGD","BK1521","LU0516422366.SGD","02269","BK1576","LU0052750758.USD","LU0819121731.USD","LU2328871848.SGD","LU0326950275.SGD","LU0516422440.USD","LU1880383366.USD","BK1588","LU1934453819.USD","BK4139","LU0823426308.USD","BK1610","LU0417516902.SGD","BK4588","LU2039709279.SGD","09969","LU0456846285.SGD","LU0572944931.SGD","LU0856984785.SGD","BK4531","LU0823426480.USD","LU1997244956.HKD","LU1997245094.SGD","LU1242518931.SGD","LU0979878070.USD","LU0456842615.SGD","LU1808992512.USD","LU2125910500.SGD","LU0307460666.USD","LU1046422090.SGD","LU1997245177.USD","LU0043850808.USD","SG9999002562.SGD","BK4548","LU2488822045.USD","SG9999002463.SGD","LU0348825331.USD","LU0359202008.SGD","BK0239","LU0327786744.USD","LU0516423174.USD","LU0516423091.SGD","BK1583","LU2242644610.SGD","LU0516422952.EUR","399441","BK1141","LU2495084118.USD","BK1574","LU0051755006.USD","BK1161","LU0181495838.USD","LU1688375341.USD","LU0359201612.USD","BK4526","BK4585","LU0140636845.USD","LU0039217434.USD","LU1794554557.SGD","LU1969619763.USD","LU0320764599.SGD","LU1979443071.USD","02359","BK0216","LU2045819591.USD","LU1720050803.USD","BK1589","LU1242518857.USD","LU0588546209.SGD","LU3063872942.SGD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2608851131","title":"2月2日长春高新跌6.14%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608851131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608851131?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:47","pubTimestamp":1770022049,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日长春高新跌6.14%创60日新低，收盘报90.01元，换手率2.73%，成交量10.9万手，成交额9.9亿元。重仓长春高新的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共31家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为14.39亿元，最新净值0.4035，较上一交易日下跌0.98%，近一年上涨12.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0075","BK0188","BK0239","BK0028","161726","000661","399441","BK0057"],"gpt_icon":0},{"id":"2607224157","title":"天溯计量：此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践","url":"https://stock-news.laohu8.com/highlight/detail?id=2607224157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607224157?lang=zh_cn&edition=full","pubTime":"2026-01-29 08:39","pubTimestamp":1769647150,"startTime":"0","endTime":"0","summary":"证券之星消息，天溯计量(301449)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好！贵司《基于多加速度传感器的医用离心机转速校准方法研究及装置研发》荣获“技术创新奖”二等奖，请问传感器领域是否形成营收？知名客户有哪些？感谢回复！祝您生活愉快天溯计量回复：尊敬的投资者您好，感谢您的提问。此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践。公司与客户的合作信息请以公司披露的信息为准。感谢您的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900006680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0221","301449"],"gpt_icon":0},{"id":"2606220429","title":"四川双马：专注于生物医药领域创新药孵化","url":"https://stock-news.laohu8.com/highlight/detail?id=2606220429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606220429?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:42","pubTimestamp":1769474535,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：问，四川双马是否有产品涉及到创新药？请董秘详答。谢谢四川双马回复：您好，公司以直投和投资孵化器平台的方式布局生物医药等科创领域，专注于生物医药领域创新药孵化，目前已在肿瘤、自身免疫、代谢、神经系统疾病等多个疾病领域，集中布局了一批处于早期阶段、产品数据具备国际竞争力的创新药企业，并采用体系化、平台化的孵化模式推动成果转化。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700007815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","161726","06978","BK0028","BK0235","399441","159992","BK0021","000935","BK1574","BK0004"],"gpt_icon":0},{"id":"2606211320","title":"成大生物最新公告：拟与控股股东等共同设立生物医药产业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2606211320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606211320?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:38","pubTimestamp":1769423898,"startTime":"0","endTime":"0","summary":"成大生物(688739.SH)公告称，公司拟与控股股东辽宁成大及其全资子公司成大沿海、公司全资子公司深圳成大生物共同投资设立成大生物医药产业投资基金（有限合伙），基金总规模不超过100,000万元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600026057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","688739","BK0239"],"gpt_icon":0},{"id":"2606971562","title":"1月26日智飞生物涨14.87%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606971562","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606971562?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:50","pubTimestamp":1769413858,"startTime":"0","endTime":"0","summary":"证券之星消息，1月26日智飞生物涨14.87%，收盘报19.85元，换手率8.77%，成交量124.06万手，成交额23.64亿元。重仓智飞生物的前十大公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为14.39亿元，最新净值0.4131，较上一交易日上涨1.27%，近一年上涨15.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064130708.USD","BK0188","LU2580892862.HKD","LU2148510915.USD","399441","161726","LU2580892789.USD","BK0046","300122","LU1328615791.USD","LU1064131003.USD","BK0077","BK0196"],"gpt_icon":0},{"id":"1199361007","title":"港股生物医药股普涨！康方生物涨超5%，荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199361007","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199361007?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:54","pubTimestamp":1769133269,"startTime":"0","endTime":"0","summary":"1月23日，港股生物医药股普涨，$康方生物(09926)$涨超5%，$荣昌生物(09995)$涨超3%，$泰格医药(03347)$、$君实生物(01877)$、$百济神州(06160)$、$药明合联(02268)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de741e781d04bd03f8ca00d2fa57ffc6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1794554557.SGD","BK1574","LU0348783233.USD","LU2328871848.SGD","161726","IE00BPRC5H50.USD","LU0417516738.SGD","LU0634319403.HKD","BK1161","LU1969619763.USD","LU0540923850.HKD","LU1064130708.USD","LU2488822045.USD","LU0348767384.USD","LU1961090484.USD","BK1583","09995","BK4588","BK1610","IE00B543WZ88.USD","LU2778985437.USD","IE00B5MMRT66.SGD","688331","LU0417516902.SGD","LABU","LU0561508036.HKD","399441","LU0348766576.USD","LU1064131003.USD","LU0348825331.USD","BK4585","LU1720050803.USD","02800","LU0348827113.USD","LU0417516571.SGD","LU0348784397.USD","LU2148510915.USD","LU2476274308.USD","LU0348735423.USD","LU2399975544.HKD","LU2476274720.SGD","09926"],"gpt_icon":0},{"id":"2605449493","title":"近五成生物医药公司业绩预喜 多家CXO企业表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2605449493","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605449493?lang=zh_cn&edition=full","pubTime":"2026-01-23 08:24","pubTimestamp":1769127883,"startTime":"0","endTime":"0","summary":"南方财经1月23日电，据中证报，截至1月22日，按照申万一级行业划分，已有逾50家生物医药企业披露2025年业绩预告，27家预喜，预喜比例近五成。值得关注的是，多家CXO（医药外包服务，包括CDMO和CRO）公司业绩表现亮眼。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601233628152649.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399441","161726","CXO","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2605450959","title":"港股异动 | 维亚生物(01873)盘中涨近7% 维亚生物创新研讨会呈现生物医药研发新路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2605450959","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605450959?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:03","pubTimestamp":1769065433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维亚生物盘中涨近7%，截至发稿，涨4.21%，报1.98港元，成交额1604.8万港元。消息面上，据维亚生物公众号，1月13日，维亚生物在第44届J.P. Morgan Healthcare Conference期间举办创新研讨会，吸引众多专业人士交流。研讨会聚焦人工智能与新药物类型前沿进展，维亚生物就AI赋能多肽药物研发全流程实验设计以及AI赋能多肽CRDMO平台展开分享，集中体现了人工智能如何在研发与产业化关键环节的加速落地，成为本次会议的重要看点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LABU","BK1141","01873","BK4588","BK1610","161726","BK1576","399441"],"gpt_icon":0},{"id":"2605141127","title":"招商基金侯昊旗下招商国证生物医药年报最新持仓，重仓药明康德","url":"https://stock-news.laohu8.com/highlight/detail?id=2605141127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605141127?lang=zh_cn&edition=full","pubTime":"2026-01-21 05:29","pubTimestamp":1768944545,"startTime":"0","endTime":"0","summary":"证券之星消息，1月21日招商基金旗下侯昊 许荣漫管理的招商国证生物医药指数基金(LOF)公布年报，近1年净值增长率16.19%。其中药明康德持仓占比9.84%，为该基金第一大重仓股；详细数据如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100003045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2045819591.USD","LU0052750758.USD","LU0320764599.SGD","LU0456842615.SGD","LU1997245094.SGD","LU2125910500.SGD","161726","BK0216","LU1997245177.USD","LU2242644610.SGD","399441","02359","BK1576","BK1583","LU1934453819.USD","LU2495084118.USD","LU2488822045.USD","BK1141","LU1808992512.USD","LU1979443071.USD","603259","LU1997244956.HKD","LU1046422090.SGD","LU2328871848.SGD","LU0708995583.HKD","LU1969619763.USD"],"gpt_icon":0},{"id":"2604185464","title":"1月19日智飞生物跌7.19%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604185464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604185464?lang=zh_cn&edition=full","pubTime":"2026-01-19 15:41","pubTimestamp":1768808495,"startTime":"0","endTime":"0","summary":"证券之星消息，1月19日智飞生物跌7.19%创60日新低，收盘报17.56元，换手率4.37%，成交量61.86万手，成交额11.02亿元。重仓智飞生物的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4203，较上一交易日下跌0.97%，近一年上涨17.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900014545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","BK0196","LU2580892789.USD","BK0046","BK0239","LU2148510915.USD","LU2580892862.HKD","BK0077","161726","LU1064131003.USD","300122","LU1328615791.USD","LU1064130708.USD","BK0188"],"gpt_icon":0},{"id":"2603635495","title":"【新股IPO】成都赜灵生物医药科技股份有限公司向港交所主板提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635495","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603635495?lang=zh_cn&edition=full","pubTime":"2026-01-13 23:43","pubTimestamp":1768318982,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所1月13日披露，成都赜灵生物医药科技股份有限公司向港交所主板提交上市申请，杰富瑞、中金公司为其联席保荐人。公司已经建立由八项专有资产组成的强大且多元化的管线，涵盖临床及临床前阶段。其中，两种候选药物已进入3期注册性临床试验阶段，包括用于治疗骨髓纤维化的FM及用于治疗复发╱难治弥漫性大B细胞淋巴瘤的PM。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NWEyNjUzNmNkZDE2ZjIxMDg2ODEwOTExNzY3Nw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NWEyNjUzNmNkZDE2ZjIxMDg2ODEwOTExNzY3Nw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973157","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","HEXmain","161726"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772110412480,"stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":-0.0413},{"period":"3month","weight":-0.0138},{"period":"6month","weight":-0.1049},{"period":"1year","weight":0.0615},{"period":"ytd","weight":0.0249}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0035},{"period":"3month","weight":0.0702},{"period":"6month","weight":0.075},{"period":"1year","weight":0.2394},{"period":"ytd","weight":0.0449}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}